The Journal of Neuroscience, May 14, 2008, 28(20):5383-5393; doi:10.1523/JNEUROSCI.5443-07.2008
Previous Article | Next Article 
Cellular/Molecular
Ketamine, But Not Phencyclidine, Selectively Modulates Cerebellar GABAA Receptors Containing
6 and
Subunits
Wulf Hevers,1,3
Stephen H. Hadley,2
Hartmut Lüddens,1 and
Jahanshah Amin2
1Carl-Ludwig Department of Physiology, University of Leipzig, D-04103 Leipzig, Germany, 2Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida 33612, and 3Laboratory of Molecular Biology at the Department of Psychiatry, University of Mainz, D-55131 Mainz, Germany
Correspondence should be addressed to Jahanshah Amin, Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL 33612. Email: Jamin{at}health.usf.edu
Phencyclidine (PCP) and ketamine are dissociative anesthetics capable of inducing analgesia, psychomimetic behavior, and a catatonic state of unconsciousness. Despite broad similarities, there are notable differences between the clinical actions of ketamine and PCP. Ketamine has a lower incidence of adverse effects and generally produces greater CNS depression than PCP. Both noncompetitively inhibit NMDA receptors, yet there is little evidence that these drugs affect GABAA receptors, the primary target of most anesthetics.
6β2/3
receptors are subtypes of the GABAA receptor family and are abundantly expressed in granular neurons within the adult cerebellum. Here, using an oocyte expression system, we show that at anesthetically relevant concentrations, ketamine, but not PCP, modulates
6β2
and
6β3
receptors. Additionally, at higher concentrations, ketamine directly activates these GABAA receptors. Comparatively, dizocilpine (MK-801 [(+)-5-methyl-10,11-dihydro-5H-dibenzo [a,d] cyclohepten-5,10-imine maleate]), a potent noncompetitive antagonist of NMDA receptors that is structurally unrelated to PCP, did not produce any effect on
6β2
receptors. Of the recombinant GABAA receptor subtypes examined (
1β2,
1β2
2,
1β2
,
4β2
2,
4β2
,
6β2
2,
6β2
, and
6β3
), the actions of ketamine were unique to
6β2
and
6β3
receptors. In dissociated granule neurons and cerebellar slice recordings, ketamine potentiated the GABAergic conductance arising from
6-containing GABAA receptors, whereas PCP showed no effect. Furthermore, ketamine potentiation was absent in cerebellar granule neurons from transgenic functionally null
6–/– and
–/–mice. These findings suggest that the higher CNS depressant level achieved by ketamine may be the result of its selective actions on
6β2/3
receptors.
Key words: ketamine;
6β2/3
GABAA receptors; granule neurons; slice recording; cerebellum; transgenic mice; tonic conductance
Received Dec. 10, 2007;
revised April 10, 2008;
accepted April 10, 2008.
Correspondence should be addressed to Jahanshah Amin, Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL 33612. Email: Jamin{at}health.usf.edu
This article has been cited by other articles:

|
 |

|
 |
 
X. Chen, S. Shu, and D. A. Bayliss
HCN1 Channel Subunits Are a Molecular Substrate for Hypnotic Actions of Ketamine
J. Neurosci.,
January 21, 2009;
29(3):
600 - 609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-S. Choi, W. Wei, J. K. Deitchman, V. N. Kharazia, H. M. B. Lesscher, T. McMahon, D. Wang, Z.-H. Qi, W. Sieghart, C. Zhang, et al.
Protein Kinase C{delta} Regulates Ethanol Intoxication and Enhancement of GABA-Stimulated Tonic Current
J. Neurosci.,
November 12, 2008;
28(46):
11890 - 11899.
[Abstract]
[Full Text]
[PDF]
|
 |
|